INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

(Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with ...

There are currently no approved treatments in Canada that can slow the progression of Alzheimer's, only drugs to quiet ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

For years, researchers have seen a connection between exercise and the progression of cognitive disorders such as Alzheimer's ...

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

A once-a-day pill that could completely revolutionise the treatment of Alzheimer’s disease has reached a significant ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

A new drug for treating early-stage Alzheimer’s disease has been administered for the first time in Taiwan on an 83-year-old ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...